Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer By Washington Examiner May 19, 2014 6:46 am FacebookTwitterEmailPrint Add Washington Examiner on Google FacebookTwitterEmailPrint LONDON (AP) — Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer. Recommended Stories Futures markets and crypto high on agenda of agency's new leaderThe global economy sure doesn't think Trump started World War IIIBig Tech executives sue Trump and Bondi over TikTok deal TagsMergers and AcquisitionsPfizerUnited Kingdom Related Content House Beatty asks court to stop Kennedy Center closure and renovation White House ‘X is not real life’: Karoline Leavitt denies MAGA divisions over Iran war Daily on Energy Daily on Energy: Quote of the week, oil prices near $100 per barrel, and storms in Oklahoma Healthcare Trump HHS undoes Biden rule forcing foster homes to affirm transgender children World How is British Columbia going to get rid of daylight saving time?
